Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Glenmark Pharm Glenmark Pharma Ltd. | BSE 2013.05 3.10 (0.15%) | NSE 2012.40 1.80 (0.09%) | Trade | Add

BSE Live

Dec 29, 12:08

2013.05 3.10 (0.15%)

Volume

AVERAGE VOLUME

5-Day

25,495

10-Day

17,687

30-Day

23,820

2,368

Prev. Close

2009.95
Open Price

2043.00

Bid Price (Qty.)
2010.75 (29)
Offer Price (Qty.)
2012.45 (8)

NSE Live

Dec 29, 12:08

2012.40 1.80 (0.09%)

Volume

AVERAGE VOLUME

5-Day

684,687

10-Day

522,249

30-Day

979,576

99,394

Prev. Close

2010.60
Open Price

2012.00

Bid Price (Qty.)
2012.20 (2)
Offer Price (Qty.)
2012.40 (16)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Glenmark Pharma (in Rs. Cr.)	Mar 10	Mar 09	Mar 08	Mar 07	Mar 06
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	1,037.15	876.71	1,413.32	838.75	620.83
Less: Excise/Sevice Tax/Other Levies	7.59	11.61	33.49	28.96	55.50
Revenue From Operations [Net]	1,029.56	865.09	1,379.82	809.79	565.34
Total Operating Revenues	1,029.56	865.09	1,379.82	809.79	565.34
Other Income	-44.10	128.63	1.39	18.24	14.38
Total Revenue	985.45	993.73	1,381.22	828.03	579.72
EXPENSES
Cost Of Materials Consumed	210.63	177.64	419.00	257.08	177.78
Purchase Of Stock-In Trade	84.15	68.72	65.49	67.65	31.32
Operating And Direct Expenses	18.37	18.11	20.52	16.86	18.26
Changes In Inventories Of FG,WIP And Stock-In Trade	-2.09	-15.16	-30.20	-50.80	1.33
Employee Benefit Expenses	115.01	110.90	108.91	78.21	60.11
Finance Costs	99.66	94.81	43.64	39.36	17.45
Depreciation And Amortisation Expenses	21.28	19.10	29.44	23.46	17.48
Other Expenses	317.42	273.22	293.24	225.39	170.68
Total Expenses	864.44	747.36	950.03	657.21	494.42
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	121.01	246.37	431.19	170.82	85.30
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	121.01	246.37	431.19	170.82	85.30
Tax Expenses-Continued Operations
Current Tax	1.75	82.98	13.45	0.60	3.84
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-9.22	-63.24	20.18	29.38	10.77
Tax For Earlier Years	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	-7.45	27.22	42.16	33.97	18.00
Profit/Loss After Tax And Before ExtraOrdinary Items	128.46	219.15	389.02	136.85	67.30
Profit/Loss From Continuing Operations	128.46	217.93	389.02	134.80	67.30
Profit/Loss For The Period	128.46	217.93	389.02	134.80	67.30
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	4.76	8.70	15.64	11.23	5.67
Diluted EPS (Rs.)	4.76	8.70	15.64	11.23	5.67
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	7.66	14.34	83.67	52.60	33.83
Indigenous Raw Materials	192.62	153.53	284.00	176.67	128.96
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	4.23	4.30	34.32	12.64	6.34
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	10.79	10.02	17.15	9.58	8.31
Tax On Dividend	1.81	1.70	2.92	1.44	1.36
Equity Dividend Rate (%)	40.00	40.00	70.00	40.00	35.00